Stay updated on Foralumab Safety in NASH and T2DM Clinical Trial
Sign up to get notified when there's something new on the Foralumab Safety in NASH and T2DM Clinical Trial page.

Latest updates to the Foralumab Safety in NASH and T2DM Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedRevision history now includes revision v3.3.2 and no longer shows revision v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check26 days agoChange DetectedRemoved the government funding operating status notice from the page, eliminating the disclaimer about potential processing delays and current operating status.SummaryDifference0.8%

- Check49 days agoChange DetectedThe version history shows updates to Study Status, Recruitment Status, and Study Design across multiple versions.SummaryDifference0.1%

- Check70 days agoChange DetectedCore content updated: a government funding and operating status notice has been added and the version updated to v3.2.0; the prior v3.1.0 tag was removed.SummaryDifference13%

- Check77 days agoChange DetectedUpdated the page version from v3.0.2 to v3.1.0, adding v3.1.0 and removing v3.0.2.SummaryDifference0.3%

- Check92 days agoChange DetectedPage revision updated from v3.0.1 to v3.0.2. The 'Back to Top' link was removed; no substantive content changes detected.SummaryDifference0.8%

Stay in the know with updates to Foralumab Safety in NASH and T2DM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Foralumab Safety in NASH and T2DM Clinical Trial page.